Best Practice & Research Clinical Obstetrics & Gynaecology
Regular ArticleRadiation therapy in endometrial cancer
References (58)
The vanishing role of preoperative radiation therapy for stage I endometrial carcinoma
International Journal of Radiation Oncology, Biology, Physics
(1991)- et al.
Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group Study
Gynecologic Oncology
(1991) - et al.
Complete surgical staging of early endometrial adenocarcinoma: optimizing patient outcomes
Seminars in Radiation Oncology
(2000) Complete surgical staging in endometrial cancer provides prognostic information only
Seminars in Radiation Oncology
(2000)Surgical staging of endometrial cancer: does the patient benefit?
Gynecologic Oncology
(1998)Surgical staging of endometrial cancer: evolution, evaluation, and responsible challenge—a personal perspective
Gynecologic Oncology
(1997)- et al.
Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling
Gynecologic Oncology
(1995) - et al.
Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma
Gynecologic Oncology
(1998) Tailoring radiation to the extent of disease for uterine-confined endometrial cancer
Seminars in Radiation Oncology
(2000)- et al.
The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma
Gynecologic Oncology
(2000)
Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy
Gynecologic Oncology
Endometrial carcinoma—relative effectiveness of adjuvant irradiation vs therapy reserved for relapse
Gynecologic Oncology
Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium
Gynecologic Oncology
Detection and patterns of treatment failure in 300 consecutive cases of ‘early’ endometrial cancer after primary surgery
Gynecologic Oncology
Surgery without radiotherapy for primary treatment of endometrial cancer
Obstetrics and Gynecology
Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma
Lancet
Benefit of external irradiation in pathologic stage I endometrial carcinoma: a prospective clinical trial of 605 patients who received postoperative vaginal irradiation and additional pelvic irradiation in the presence of unfavorable prognostic factors
Gynecologic Oncology
Improved outcome in patients treated with postoperative radiation therapy for pathologic stage I/II endometrial cancer
International Journal of Radiation Oncology, Biology, Physics
The role of adjuvant radiotherapy in carcinoma of the endometrium—results in 550 patients with pathologic stage I disease
Gynecologic Oncology
Which prognostic factors influence the outcome of patients with surgically staged endometrial cancer treated with adjuvant radiation?
International Journal of Radiation Oncology, Biology, Physics
Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial
International Journal of Radiation Oncology, Biology, Physics
High-dose-rate postoperative vaginal cuff irradiation alone for stage IB and IC endometrial cancer
International Journal of Radiation Oncology, Biology, Physics
Adjuvant vaginal high-dose-rate afterloading alone in endometrial carcinoma: patterns of relapse and side effects following low-dose therapy
Gynecologic Oncology
High-dose-rate brachytherapy alone post-hysterectomy for endometrial cancer
International Journal of Radiation Oncology, Biology, Physics
Clarity and confusion regarding adjuvant radiation therapy in early endometrial cancer
Gynecologic Oncology
The use of adjuvant radiation therapy by members of the Society of Gynecologic Oncologists
Gynecologic Oncology
Role of whole abdominal radiation therapy in the management of endometrial cancer; prognostic importance of factors indicating peritoneal metastases
Gynecologic Oncology
Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease
Gynecologic Oncology
Cited by (18)
Survival outcome in endometrial cancer patients according to hereditary predisposition
2015, Taiwanese Journal of Obstetrics and GynecologyCitation Excerpt :All patients underwent total hysterectomy and pelvic lymph node dissection, with or without para-aortic lymph node dissection. Adjuvant pelvic radiation after complete surgical staging was performed in patients with potential adverse risk factors such as age, grade, lymphovascular invasion, tumor size, lower uterine involvement, and outer-third myometrial invasion [11–13]. Adjuvant chemotherapy was performed in patients with Stage IVb disease or concurrent ovarian cancer.
Endometrial Cancer
2015, Clinical Radiation OncologyEndometrial Cancer
2012, Clinical Radiation Oncology: Third EditionEndometrial Cancer
2011, Clinical Radiation Oncology, Third EditionLymphovascular space invasion does not predict vaginal relapses in stage I endometrioid adenocarcinoma of the endometrium
2008, Annals of Diagnostic PathologyCitation Excerpt :The reported salvage rates for these patients have been variable, ranging from 67% to 89% in 3 major reports [31,33,34]. Although the use of adjuvant radiotherapy (high and/or low dose vaginal cuff brachytherapy and/or external beam radiotherapy) in reducing the locoregional relapse rates for stage 1 endometrial cancers has been noted in several reports [22-24,27-32], there continues to be a lack ofconsensus among clinical practitioners with respect to which group of patients is best suited to receive adjuvantradiotherapy [35,36]. This lack of consensus is most glaring for surgically staged FIGO stage 1B endometrioid adenocarcinoma, grades 1 and 2, in which some practitioners advocate no postoperative radiotherapy; whereas others advocate vaginal cuff brachytherapy [35,36].
- f1
To whom correspondence should be addressed.